AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (July 27, 2004). doi:10.1152/ajpendo.00047.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/5/E896    most recent
00047.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shen, X.
Right arrow Articles by Epstein, P. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, X.
Right arrow Articles by Epstein, P. N.
Submitted on February 2, 2004
Accepted on July 16, 2004

Cardiac Mitochondrial Damage and Biogenesis in a Chronic Model of Type I Diabetes

Xia Shen1, Shirong Zheng2, Visith Thongboonkerd3, Ming Xu2, William M. Pierce Jr.4, Jon B. Klein5, and Paul N. Epstein1*

1 Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, USA; Department of Pediatrics, University of Louisville, Louisville, KY, USA
2 Department of Pediatrics, University of Louisville, Louisville, KY, USA
3 Core Proteomics Laboratory, Kidney Disease Program, Department of Medicine, University of Louisville, Louisville, KY, USA; Medical Molecular Biology Unit, Office for Reaseach and Development, Faculty of Medicine at Siriraj Hospital, Mahidol University, Bangkok, Thailand
4 Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, USA
5 Core Proteomics Laboratory, Kidney Disease Program, Department of Medicine, University of Louisville, Louisville, KY, USA; Veterans Affairs Medical Center, Louisville, KY, USA; Department of Biochemistry and Molecular Biology, University of Louisville, Louisville, KY, USA

* To whom correspondence should be addressed. E-mail: paul.epstein{at}louisville.edu.

Diabetic cardiomyopathy is a common complication leading to heightened risk of heart failure and death. In the present report, we performed proteomic analysis on total cardiac proteins from the OVE26 mouse model of Type I diabetes to identify protein changes that may contribute to diabetic cardiomyopathy. This analysis revealed that a surprising high proportion (twelve out of twenty) of the altered proteins that could be identified by mass spectrometry were of mitochondrial origin. All but one of these proteins were up-regulated by diabetes. Quantitative RT-PCR, performed for two of these proteins indicated that part of the up-regulation was attributed to increased messenger RNA levels. Morphological study of diabetic hearts showed significantly increased mitochondrial area and number, as well as focal regions with severe damage to mitochondria. Diabetic mitochondria also showed reduced respiratory control ratio (9.63 ± 0.20 vs. 6.13 ± 0.41, p<0.0001) apparently due to reduced state 3 rate, and diminished GSH level (5.5 ± 0.9 vs. 8.2 ± 2.5 µmol/mg protein, p<0.05), indicating impaired mitochondrial function and increased oxidative stress. Further examination revealed increased mitochondrial DNA (1.03 ± 0.18 vs 0.69 ± 0.13 relative copy number, p<0.001) and a tendency to higher protein yield in OVE26 cardiac mitochondria, as well as increased mRNA level for mitochondrial transcription factor A (Tfam) and two mitochondrial-encoded proteins. Taken together, these results show that mitochondria are a primary target in the diabetic heart, probably due to oxidative stress, and that this damage coincides with and may stimulate mitochondrial biogenesis.




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
E. D. Abel, S. E. Litwin, and G. Sweeney
Cardiac Remodeling in Obesity
Physiol Rev, April 1, 2008; 88(2): 389 - 419.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. G. Abraham and A. Kappas
Pharmacological and Clinical Aspects of Heme Oxygenase
Pharmacol. Rev., March 1, 2008; 60(1): 79 - 127.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Boudina, S. Sena, H. Theobald, X. Sheng, J. J. Wright, X. X. Hu, S. Aziz, J. I. Johnson, H. Bugger, V. G. Zaha, et al.
Mitochondrial Energetics in the Heart in Obesity-Related Diabetes: Direct Evidence for Increased Uncoupled Respiration and Activation of Uncoupling Proteins
Diabetes, October 1, 2007; 56(10): 2457 - 2466.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. P. Alcolea, I. Llado, F. J. Garcia-Palmer, and M. Gianotti
Responses of mitochondrial biogenesis and function to maternal diabetes in rat embryo during the placentation period
Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E636 - E644.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Boudina and E. D. Abel
Diabetic Cardiomyopathy Revisited
Circulation, June 26, 2007; 115(25): 3213 - 3223.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. Hsueh, E. D. Abel, J. L. Breslow, N. Maeda, R. C. Davis, E. A. Fisher, H. Dansky, D. A. McClain, R. McIndoe, M. K. Wassef, et al.
Recipes for Creating Animal Models of Diabetic Cardiovascular Disease
Circ. Res., May 25, 2007; 100(10): 1415 - 1427.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. Nisoli, E. Clementi, M. O. Carruba, and S. Moncada
Defective Mitochondrial Biogenesis: A Hallmark of the High Cardiovascular Risk in the Metabolic Syndrome?
Circ. Res., March 30, 2007; 100(6): 795 - 806.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. G. Duncan, J. L. Fong, D. M. Medeiros, B. N. Finck, and D. P. Kelly
Insulin-Resistant Heart Exhibits a Mitochondrial Biogenic Response Driven by the Peroxisome Proliferator-Activated Receptor-{alpha}/PGC-1{alpha} Gene Regulatory Pathway
Circulation, February 20, 2007; 115(7): 909 - 917.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H.-C. Lai, T.-J. Liu, C.-T. Ting, J.-Y. Yang, L. Huang, D. Wallace, P. Kaiser, and P. H. Wang
Regulation of IGF-I receptor signaling in diabetic cardiac muscle: dysregulation of cytosolic and mitochondria HSP60
Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E292 - E297.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. An and B. Rodrigues
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1489 - H1506.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
S. Boudina and E. D. Abel
Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes.
Physiology, August 1, 2006; 21: 250 - 258.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Di Noia, S. Van Driesche, F. Palmieri, L.-M. Yang, S. Quan, A. I. Goodman, and N. G. Abraham
Heme Oxygenase-1 Enhances Renal Mitochondrial Transport Carriers and Cytochrome c Oxidase Activity in Experimental Diabetes
J. Biol. Chem., June 9, 2006; 281(23): 15687 - 15693.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
X. Shen, S. Zheng, N. S. Metreveli, and P. N. Epstein
Protection of Cardiac Mitochondria by Overexpression of MnSOD Reduces Diabetic Cardiomyopathy
Diabetes, March 1, 2006; 55(3): 798 - 805.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Ghosh, T. Pulinilkunnil, G. Yuen, G. Kewalramani, D. An, D. Qi, A. Abrahani, and B. Rodrigues
Cardiomyocyte apoptosis induced by short-term diabetes requires mitochondrial GSH depletion
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H768 - H776.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.